Identification Generic Name [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine DrugBank Accession Number DB04109 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine (DB04109) ×  Close Weight Average: 221.041  Monoisotopic: 221.10974779  Chemical Formula C 10 H 14 BN 2 O 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Trypsin-3 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Not Available Direct Parent Benzene and substituted derivatives Alternative Parents Dioxaborolanes  /  Oxacyclic compounds  /  Organic metalloid salts  /  Carboximidamides  /  Carboxamidines  /  Organopnictogen compounds  /  Organooxygen compounds  /  Organic oxoanionic compounds  /  Hydrocarbon derivatives  /  Organic cations Substituents 1,3,2-dioxaborolane  /  Amidine  /  Aromatic heteromonocyclic compound  /  Carboximidamide  /  Carboxylic acid amidine  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic borate  /  Organic cation  /  Organic metalloid salt Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key XCLFQXCQQHVLJQ-UHFFFAOYSA-O InChI InChI=1S/C10H13BN2O3/c12-10(13)9-3-1-8(2-4-9)7-16-11-14-5-6-15-11/h1-4H,5-7H2,(H3,12,13)/p+1 IUPAC Name [amino({4-[(1,3,2-dioxaborolan-2-yloxy)methyl]phenyl})methylidene]azanium SMILES NC(=[NH2+])C1=CC=C(COB2OCCO2)C=C1 References General References Not Available External Links PubChem Compound 5289339 PubChem Substance 46505423 ChemSpider 4451329 PDBe Ligand SBZ PDB Entries 1s85 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.4 mg/mL ALOGPS logP -0.5 ALOGPS logP 2.27 Chemaxon logS -2.8 ALOGPS pKa (Strongest Basic) 11.47 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 79.3 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 66.26 m 3 ·mol -1 Chemaxon Polarizability 24.28 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.5386 Blood Brain Barrier + 0.94 Caco-2 permeable - 0.6349 P-glycoprotein substrate Non-substrate 0.6903 P-glycoprotein inhibitor I Non-inhibitor 0.927 P-glycoprotein inhibitor II Non-inhibitor 0.9713 Renal organic cation transporter Non-inhibitor 0.6119 CYP450 2C9 substrate Non-substrate 0.7998 CYP450 2D6 substrate Non-substrate 0.7955 CYP450 3A4 substrate Non-substrate 0.7155 CYP450 1A2 substrate Non-inhibitor 0.6855 CYP450 2C9 inhibitor Non-inhibitor 0.7928 CYP450 2D6 inhibitor Non-inhibitor 0.8638 CYP450 2C19 inhibitor Non-inhibitor 0.7562 CYP450 3A4 inhibitor Non-inhibitor 0.9771 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9263 Ames test Non AMES toxic 0.5774 Carcinogenicity Non-carcinogens 0.8883 Biodegradation Not ready biodegradable 0.9529 Rat acute toxicity 2.4887 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7565 hERG inhibition (predictor II) Non-inhibitor 0.921    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Trypsin-3 Kind Protein Organism Humans Pharmacological action Unknown General Function Serine-type peptidase activity Specific Function Digestive protease specialized for the degradation of trypsin inhibitors. In the ileum, may be involved in defensin processing, including DEFA5. Gene Name PRSS3 Uniprot ID P35030 Uniprot Name Trypsin-3 Molecular Weight 32528.565 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 